ClinicalTrials.gg
RecruitingNCT04092855PACEPORTUpdated Mar 19, 2024

Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery

An observational study in Right Ventricular Dysfunction, Right Heart Failure and Congestive Heart Failure, sponsored by Montreal Heart Institute. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-19.

Sponsored by Montreal Heart Institute · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Dec 2018; still recruiting 7 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
112
Ages
18 Years and older
Sex
All
01

Study summary

RV dysfunction has been associated with increased mortality in the ICU and cardiac surgical patients. Thus, early identification of RV dysfunction at less severe stages will allow for earlier intervention and potentially better patient outcomes.

However, so far, no studies have reported prospectively the prevalence of abnormal RV pressure waveform during cardiac surgery and in the ICU. The investigator's primary hypothesis is that the prevalence of abnormal RV pressure waveform occurs in more than 50% of cardiac surgical patients throughout their hospitalization. Those patients with abnormal RV pressure waveform will be more prone to post-operative complications related to RV dysfunction and failure in the OR and ICU.

Read the detailed description

Right ventricular (RV) dysfunction is mostly associated to a decrease in contractility, right ventricular pressure overload or right ventricular volume overload. RV dysfunction can occur in a number of clinical scenarios in the intensive care unit (ICU) and operating room (OR): pulmonary embolism, acute respiratory distress syndrome (ARDS), septic shock, RV infarction, and in pulmonary hypertensive patients undergoing cardiac surgery.

Unfortunately, identifying which patients will develop RV dysfunction and then progress towards RV failure have proven difficult. One of the reasons for delaying the diagnosis of RV dysfunction could be the lack of uniform definition, especially in the perioperative period. Echocardiographic definitions of RV dysfunction have been described: RV fractional area change (RVFAC) \< 35 %, tricuspid annular plane systolic excursion (TAPSE) \< 16 mm, tissue Doppler S wave velocity \<10 cm/s, RV ejection fraction (RVEF) \<45% and RV dilation. However, echocardiographic indices alone are insufficient in describing RV function. The diagnosis of fulminant RV failure is more easily recognised as a combination of echocardiographic measures, compromised hemodynamic measures and clinical presentation. RV dysfunction is inevitably associated with absolute or relative pulmonary hypertension because of the anatomic and physiological connection between the RV and pulmonary vascular system. The gold standard for measuring pulmonary pressure is still the pulmonary artery catheter. However, RV output can initially be preserved despite of pulmonary hypertension. It is therefore mandatory that early, objective, continuous, easily obtainable and subclinical indices of RV dysfunction are found and validated to initiate early treatment of this disease.

02

Conditions studied

  • Right Ventricular Dysfunction
  • Right Heart Failure
  • Congestive Heart Failure

Keywords

  • Right Ventricular Pressure Waveform
03

In context

Ventricular Dysfunction, Right

90 studies on the registry are indexed under Ventricular Dysfunction, Right; 28 are open to participants now.

This study's planned enrollment of 112 is above the median of 100 across 51 observational studies indexed under Ventricular Dysfunction, Right.

Browse Ventricular Dysfunction, Right studies →

Lead sponsor

Montreal Heart Institute is the lead sponsor of 101 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients undergoing cardiac surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-Male or female patients, age 18 and older, undergoing cardiac surgery and receiving standard of care monitoring utilizing a pulmonary artery catheter.

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery or inability to obtain consent
  • Concomitant diseases such as pericardial constriction, congenital heart disease, severe valvular regurgitation, right ventricular systolic dysfunction, or right ventricular infarction.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
112 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Proportion of abnormal diastolic RV waveforms before CPB, after CPB and in the ICU

    Abnormal RV pressure waveform will be defined as a difference between the RV end-diastolic minus the early-diastolic pressure \> 4 mmHg.

    Time frame: From thermodilution catheter insertion until 2 hours after ICU arrival

Secondary outcomes

  1. Proportion of patients with difficult and complex separation from cardiopulmonary bypass at the end of cardiac surgery

    Difficult separation from cardiopulmonary bypass: instability requiring at least two different types of pharmacological agents (i.e., inotropes ± vasopressors ± inhaled agents) Complex separation from cardiopulmonary bypass: Hemodynamic instability requiring return on cardiopulmonary bypass or addition of mechanical support (intra-aortic balloon pump or extra-corporeal membrane oxygenator)

    Time frame: From the discontinuation of cardiopulmonary bypass until ICU arrival after surgery, assessed up to 4 hours.

  2. Cumulative time of Persistent Organ Dysfunction or Death (TPOD) during the first 28 days after cardiac surgery

    TPOD is a continuous variable representative of the burden of care and morbidity during the first 28 days following cardiac surgery and was chosen to circumvent issues arising for using other clinical endpoint such as ICU length of stay

    Time frame: Up to 28 days or until hospital discharge

  3. Incidence of deaths during hospitalisation

    Death from any cause

    Time frame: Up to 30 days or until hospital discharge

  4. Incidence of acute kidney injury (AKI)

    Acute kidney injury (AKI) according to KDIGO serum creatinine criteria: Stage 1: ≥50% or 27 umol/L increases in serum creatinine, Stage 2: ≥100% increase in serum creatinine, Stage 3 ≥200% increase in serum creatinine or an increase to a level of ≥254 umol/L or dialysis initiation.

    Time frame: Up to 28 days or until hospital discharge

  5. Incidence of major bleeding

    Major bleeding is defined by the Bleeding Academic Research Consortium (BARC) as one of the following: * Perioperative intracranial bleeding within 48h * Reoperation after closure of sternotomy for the purpose of controlling bleeding * Transfusion of ≥5 units of whole blood of packed red blood cells within a 48 hours period * Chest tube output ≥2L within a 24 hours period

    Time frame: Up to 28 days or until hospital discharge

  6. Incidence of surgical reintervention for any reasons

    Re-operation after the initial surgery for any cause

    Time frame: Up to 28 days or until hospital discharge

  7. Incidence of deep sternal wound infection or mediastinitis

    Diagnosis of a deep incisional surgical site infection or mediastinitis by a surgeon or attending physician

    Time frame: Up to 28 days or until hospital discharge

  8. Incidence of delirium

    Delirium is defined as an intensive care delirium screening checklist (ICDSC) score(18) of ≥4 in the week following surgery or positive result for the Confusion Assessment Method for the ICU (CAM-ICU).

    Time frame: Up to 28 days or until hospital discharge

  9. Incidence of stroke

    Central neurologic deficit persisting longer than 72 hours

    Time frame: Up to 28 days or until hospital discharge

  10. Total duration of ICU stay in hours

    Number of hours passed in the ICU

    Time frame: Up to 28 days or until hospital discharge

  11. Duration of vasopressor requirements (in hours)

    Vasopressors include norepinephrine, epinephrine, dobutamine, vasopressin, phenylephrine, milrinone, isoproterenol and dopamine.

    Time frame: Up to 28 days or until hospital discharge

  12. Duration of hospital stay (in days)

    Number of days hospitalized from the day of surgery to discharge

    Time frame: Up to 28 days or until hospital discharge

  13. Duration of mechanical ventilation (in hours)

    A duration of \>24 hours will be considered prolonged ventilation requirements.

    Time frame: Up to 28 days or until hospital discharge

  14. Incidence of major morbidity or mortality

    Including death, prolonged ventilation, stroke, renal failure (Stage ≥2), deep sternal wound infection and reoperation for any reason.

    Time frame: Up to 28 days or until hospital discharge

  15. Right ventricular ejection fraction

    Assessed by the American Society of Echocardiography guidelines

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  16. Right ventricular fractional area change

    Assessed by the American Society of Echocardiography guidelines

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  17. Right ventricular strain

    Assessed by the American Society of Echocardiography guidelines

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  18. Tricuspid annular plane systolic excursion

    Assessed by the American Society of Echocardiography guidelines

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  19. Right ventricular performance index

    Assessed by the American Society of Echocardiography guidelines

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  20. Portal flow pulsatility fraction

    Defined as the difference between the maximal and the minimal velocity during the cardiac cycle divided by the maximal velocity

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  21. Right ventricular stroke work index

    0.0136x Stroke volume index x (Mean pulmonary artery pressure-mean right atrial pressure)

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  22. Relative pulmonary pressure

    The ratio of the mean systemic arterial pressure divided by the mean pulmonary artery pressure

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  23. Right ventricular function index

    Defined as (isovolumic contraction time + isovolumic relaxation time)/RV ejection time

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  24. Pulmonary artery pulsatility index (PAPi)

    Defined as (systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/central venous pressure\]

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  25. Compliance of the pulmonary artery (CPA)

    Stroke volume divided by the pulmonary artery pulse pressure (systolic minus the diastolic pulmonary artery pressure)

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

  26. Pulsatility of femoral venous flow

    Velocity variations of blood flow in the femoral vein during the cardiac cycle

    Time frame: From arrival to the operating room until 2 hours after ICU arrival

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008 Apr 1;117(13):1717-31. doi: 10.1161/CIRCULATIONAHA.107.653584. No abstract available. PubMed 18378625 ↗
  • Denault AY, Bussières J, Carrier M, Mathieu P, and the DSBSG. The importance of difficult separation from cardiopulmonary bypass: the Montreal and Quebec Heart Institute experience. Exp Clin Cardiol. 2006;11 (1):37.
  • Denault AY, Bussieres JS, Arellano R, Finegan B, Gavra P, Haddad F, Nguyen AQN, Varin F, Fortier A, Levesque S, Shi Y, Elmi-Sarabi M, Tardif JC, Perrault LP, Lambert J. A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients. Can J Anaesth. 2016 Oct;63(10):1140-1153. doi: 10.1007/s12630-016-0709-8. Epub 2016 Jul 28. PubMed 27470232 ↗
  • Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010. No abstract available. PubMed 20620859 ↗
  • Raymond M, Gronlykke L, Couture EJ, Desjardins G, Cogan J, Cloutier J, Lamarche Y, L'Allier PL, Ravn HB, Couture P, Deschamps A, Chamberland ME, Ayoub C, Lebon JS, Julien M, Taillefer J, Rochon A, Denault AY. Perioperative Right Ventricular Pressure Monitoring in Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019 Apr;33(4):1090-1104. doi: 10.1053/j.jvca.2018.08.198. Epub 2018 Aug 25. PubMed 30269893 ↗
  • Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg. 2009 Feb;108(2):407-21. doi: 10.1213/ane.0b013e31818f8623. PubMed 19151264 ↗
  • Naeije R, Manes A. The right ventricle in pulmonary arterial hypertension. Eur Respir Rev. 2014 Dec;23(134):476-87. doi: 10.1183/09059180.00007414. PubMed 25445946 ↗
  • Denault AY, Chaput M, Couture P, Hebert Y, Haddad F, Tardif JC. Dynamic right ventricular outflow tract obstruction in cardiac surgery. J Thorac Cardiovasc Surg. 2006 Jul;132(1):43-9. doi: 10.1016/j.jtcvs.2006.03.014. PubMed 16798301 ↗
  • Denault A, Lamarche Y, Rochon A, Cogan J, Liszkowski M, Lebon JS, Ayoub C, Taillefer J, Blain R, Viens C, Couture P, Deschamps A. Innovative approaches in the perioperative care of the cardiac surgical patient in the operating room and intensive care unit. Can J Cardiol. 2014 Dec;30(12 Suppl):S459-77. doi: 10.1016/j.cjca.2014.09.029. Epub 2014 Oct 5. PubMed 25432139 ↗
  • St-Pierre P, Deschamps A, Cartier R, Basmadjian AJ, Denault AY. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma. J Cardiothorac Vasc Anesth. 2014 Jun;28(3):723-9. doi: 10.1053/j.jvca.2012.10.017. Epub 2013 Apr 26. No abstract available. PubMed 23623891 ↗
  • Amsallem M, Kuznetsova T, Hanneman K, Denault A, Haddad F. Right heart imaging in patients with heart failure: a tale of two ventricles. Curr Opin Cardiol. 2016 Sep;31(5):469-82. doi: 10.1097/HCO.0000000000000315. PubMed 27467173 ↗
  • Korshin A, Gronlykke L, Nilsson JC, Moller-Sorensen H, Ihlemann N, Kjoller M, Damgaard S, Lehnert P, Hassager C, Kjaergaard J, Ravn HB. The feasibility of tricuspid annular plane systolic excursion performed by transesophageal echocardiography throughout heart surgery and its interchangeability with transthoracic echocardiography. Int J Cardiovasc Imaging. 2018 Jul;34(7):1017-1028. doi: 10.1007/s10554-018-1306-4. Epub 2018 Jan 30. PubMed 29383465 ↗
  • Hrymak C, Strumpher J, Jacobsohn E. Acute Right Ventricle Failure in the Intensive Care Unit: Assessment and Management. Can J Cardiol. 2017 Jan;33(1):61-71. doi: 10.1016/j.cjca.2016.10.030. Epub 2016 Nov 11. PubMed 28024557 ↗
  • Stoppe C, McDonald B, Benstoem C, Elke G, Meybohm P, Whitlock R, Fremes S, Fowler R, Lamarche Y, Jiang X, Day AG, Heyland DK. Evaluation of Persistent Organ Dysfunction Plus Death As a Novel Composite Outcome in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2016 Jan;30(1):30-8. doi: 10.1053/j.jvca.2015.07.035. Epub 2015 Jul 29. PubMed 26847748 ↗
  • Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF Jr, Bernard GR. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med. 1999 Jul;160(1):358-67. doi: 10.1164/ajrccm.160.1.9807118. No abstract available. PubMed 10390426 ↗
  • Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454. PubMed 23394211 ↗
  • Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449. No abstract available. PubMed 21670242 ↗
  • Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001 May;27(5):859-64. doi: 10.1007/s001340100909. PubMed 11430542 ↗
  • Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941. PubMed 2240918 ↗
  • Sun LY, Chung AM, Farkouh ME, van Diepen S, Weinberger J, Bourke M, Ruel M. Defining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery. Anesthesiology. 2018 Sep;129(3):440-447. doi: 10.1097/ALN.0000000000002298. Erratum In: Anesthesiology. 2019 Feb;130(2):360. doi: 10.1097/ALN.0000000000002496. PubMed 29889106 ↗
  • Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S2-22. doi: 10.1016/j.athoracsur.2009.05.053. PubMed 19559822 ↗
  • Denault AY, Pearl RG, Michler RE, Rao V, Tsui SS, Seitelberger R, Cromie M, Lindberg E, D'Armini AM. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial. J Cardiothorac Vasc Anesth. 2013 Dec;27(6):1212-7. doi: 10.1053/j.jvca.2013.01.023. Epub 2013 Mar 21. PubMed 23523254 ↗
  • Ait-Oufella H, Bourcier S, Alves M, Galbois A, Baudel JL, Margetis D, Bige N, Offenstadt G, Maury E, Guidet B. Alteration of skin perfusion in mottling area during septic shock. Ann Intensive Care. 2013 Sep 16;3(1):31. doi: 10.1186/2110-5820-3-31. PubMed 24040941 ↗
  • Vieillard-Baron A, Naeije R, Haddad F, Bogaard HJ, Bull TM, Fletcher N, Lahm T, Magder S, Orde S, Schmidt G, Pinsky MR. Diagnostic workup, etiologies and management of acute right ventricle failure : A state-of-the-art paper. Intensive Care Med. 2018 Jun;44(6):774-790. doi: 10.1007/s00134-018-5172-2. Epub 2018 May 9. PubMed 29744563 ↗
  • Beaubien-Souligny W, Benkreira A, Robillard P, Bouabdallaoui N, Chasse M, Desjardins G, Lamarche Y, White M, Bouchard J, Denault A. Alterations in Portal Vein Flow and Intrarenal Venous Flow Are Associated With Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Cohort Study. J Am Heart Assoc. 2018 Oct 2;7(19):e009961. doi: 10.1161/JAHA.118.009961. PubMed 30371304 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04092855
Responsible party
Andre Denault (Principal Investigator, Montreal Heart Institute) — Principal investigator
First posted
Sep 17, 2019
Start date
Dec 10, 2018
Primary completion
Sep 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Mar 19, 2024

Study contacts

Sophie Robichaud, RRT
Contact
sophie.robichaud@icm-mhi.org
5143763330 ext. 3305
Samuel Côté, RRT
Contact
samuel.cote@icm-mhi.org
5143763330 ext. 4262
Andre Denault, MD,PhD
principal investigator · Montreal Heart Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion